与免疫检查点抑制剂相关的重叠肝毒性和结肠炎
Alexander Malik1, Muhammad N Yousaf2, Sami Samiullah3
1Department of Medicine, Summa Health System, Akron, OH, United States.
Journal of community hospital internal medicine perspectives
|October 25, 2023
概括
同时免疫检查点抑制剂 (ICI) 相关的肝炎和结肠炎是一种罕见但严重的不良事件. 早期识别和及时治疗对于在癌症患者中管理这些重叠的毒性至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 免疫检查点抑制剂 (ICI),如CTLA-4,PD-1和PD-L1抑制剂,在癌症治疗中至关重要.
- 免疫系统过度活化可能导致不良事件,包括器官特异性毒性.
- 由ICI引起的同时发生的肝毒性和大肠炎是罕见的,并且经常伴有非特异性症状.
研究的目的:
- 为了突出ICI相关性肝炎和结肠炎重叠的罕见情况.
- 强调对这些并发不良事件的临床怀疑的重要性.
- 讨论ICI引起的结合性肝脏和结肠损伤的管理策略.
主要方法:
- 一个73岁的男性患有转移性状细胞癌的病例报告,他接受了 pembrolizumab 的治疗.
- 腹部不适和腹的临床表现.
- 在开始服用pembrolizumab后,诊断ICI相关的肝炎和ICI相关的结肠炎.
主要成果:
- 患者同时发展出ICI相关的肝炎和结肠炎.
- 停用布罗利祖马布和支持性护理为腹提供了部分缓解.
- 皮质类固醇是需要大肠炎的解决方案.
结论:
- 覆盖ICI相关的肝炎和结肠炎,虽然很少见,但需要高临床怀疑指数.
- 及时识别,停止使用药物和早期支持性治疗,可能包括皮质类固醇,是必不可少的.
- 有效的管理需要及时干预,以防止严重的并发症.
更多相关视频
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
192
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
192
Drugs for Treatment of Ulcerative Colitis in IBD
149
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
149
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
148
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
148
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
122
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
122
Hepatic Drug Excretion: Influencing Factors
134
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
134


